Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION

v3.24.3
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2024
Equity [Abstract]  
STOCK-BASED COMPENSATION

NOTE 11 – STOCK-BASED COMPENSATION

 

In January 2021, the Company’s board of directors adopted the Volcon, Inc. 2021 Stock Plan, (the “2021 Plan”). The 2021 Plan is a stock-based compensation plan that provides for discretionary grants of stock options, stock awards, and restricted stock unit awards to employees, members of the board of directors and consultants (including restricted stock units issued prior to the adoption of the plan as further discussed below). The Company has reserved 39 shares of the Company’s common stock for issuance under the 2021 Plan. To the extent that an award, if forfeitable, expires, terminates or lapses, or an award is otherwise settled in cash without the delivery of shares of common stock to the participant, then any unpaid shares subject to the award will be available for future grant or issuance under the 2021 Plan. There are no shares available for issuance under the 2021 Plan as of September 30, 2024. Awards vest according to each agreement and as long as the employee remains employed with the Company or the consultant continues to provide services in accordance with the terms of the agreement.

 

Restricted Stock Units

 

There were no restricted stock units outstanding in 2024 and no expense was recognized for any period of 2024. In February 2023, 1 RSU was subject to cancellation due to termination of employment. However, the Company entered into a modification to allow the employee to fully vest in these RSUs as part of a severance agreement. The Company recorded additional expense of $31,487 during the nine months ended September 30, 2023 related to this modification.

 

For the three and nine months ended September 30, 2023, the Company recognized (benefit) expense for RSUs of $(15,700) and $61,623, respectively.

 

Performance Shares

 

In 2022 the compensation committee approved reserving 2 shares from the 2021 Plan to issue based on achievement of the Company’s 2022 performance milestones to employees who are employed in 2022 and were active employees on the date of approval in 2023 by the compensation committee. On February 6, 2023 the compensation committee of the board of directors approved a grant of 1 share for the achievement of some of the Company’s 2022 performance milestones. The Company recognized share-based compensation expenses of $257,717 related to the grant of these shares in the nine months ended September 30, 2023.

 

In addition, the compensation committee also approved reserving 2 shares from the 2021 Plan to issue to employees based on achievement of the Company’s 2023 performance milestones to employees who were employed in 2023 and are active employees on the date of approval in 2024 by the compensation committee. No shares were approved for grant by the compensation committee for 2023 performance milestones.

 

Stock Options

 

The following summarizes activity relating to common stock options to employees and consultants for services during the nine months ended September 30, 2024:

                       
    Common Stock Options  
    Shares     Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in years
    Intrinsic Value  
Outstanding at January 1, 2024     61     $ 354,819.26                  
Granted*     6,251     $ 13.00                  
Forfeited     (11 )   $ 163,500                  
Canceled     (12 )   $ 712,350                  
Outstanding at September 30, 2024     6,289     $ 1,812.00       9.88     $ 0  
Exercisable at September 30, 2024     38     $ 303,087.00       8.11     $ 0  

 

* Includes 50,000 inducement options granted outside of the 2021 Plan.

 

The Company valued the options using the closing stock price of the Company’s common stock on the date of grant and the following assumptions:

           
    2024     2023  
Volatility (based on the Company’s volatility in 2024 and peer companies in 2023)     152% - 170%       79% - 83%  
Risk free interest rate     4.0% - 4.5%       3.54% - 4.77%  
Dividends     None       None  
Estimated life in years     6       6  

 

During the three and nine months ended September 30, 2024, the Company recognized share-based compensation (benefit) expense of $10,053 and $295,882, respectively, related to common stock options. The share-based compensation for the nine months ended September 30, 2024 includes a net benefit of $1,922 for the three months ended March 31, 2024 primarily due to forfeiture of unvested stock options from employees who terminated during the period ended March 31, 2024, which offset the expense from stock options outstanding for current employees. During the three and nine months ended September 30, 2023 the Company recognized share-based compensation expenses of $556,228, and $1,904,016, respectively, related to common stock options. The Company expects to recognize additional compensation expense of $70,368 related to these common stock options assuming all awards will vest.

 

Total stock-based compensation recorded for the three and nine months ended September 30, 2024 and 2023 for all stock-based compensation awards, including warrants, has been recorded as follows:

                       
   

Three Months
Ended

September 30,

2024

   

Three Months
Ended

September 30,

2023

   

Nine Months
Ended

September 30,

2024

   

Nine Months
Ended

September 30,

2023

 
Cost of Goods Sold   $     $ 131,525     $ (11,827 )   $ 487,605  
Sales and Marketing     10,053       134,073       21,984       678,945  
Product Development           80,759       126,337       389,729  
General and Administrative           194,171       159,388       667,077  
Total   $ 10,053     $ 540,528     $ 295,882     $ 2,223,356